The ESMO World Congress on Gastrointestinal Cancer Virtual Meeting took place on 1 – 4 July 2020. Experts in the field came together online to present the latest practice-changing data in GI cancer.
Hot topics at this year’s meeting included the use of combination immunotherapy, targeted therapies and novel treatment approaches.
Updates from the latest clinical trials were received, including data from Checkmate 459, CAIRO6, and the DELIVER trial.
VIDEO: APROMISS: anlotinib versus dacarbazine in advanced synovial #Sarcoma w/ @RobinL_Jones of @royalmarsdenNHS 📣 Watch here: http://ow.ly/1w4e50FzHHo @VJOncology @OncoAlert @ASCO #ASCO2021 #SCMsm #Oncology #SarcomaAwarenessMonth #BoneCancerAwarenessMonth
James Larkin (@royalmarsdenNHS) gives us a sneak preview of the upcoming #skincancer roundtable on 28th July 📆 He's joined by @AnaArance1, @PAscierto & Rodabe Amaria as they discuss the key #ASCO2021 #SKCsm data! 🔎 Register now 👉 https://bit.ly/3xTq5pg @ASCO @OncoAlert
#EAU21 offered fascinating updates and insights in urological cancers and we’re still here to share them with you! Missed a key presentation, or wanted to hear it again? Check out 👉http://VJOncology.com👈 @VJOncology @Uroweb @OncoAlert #PCsm #BLCsm #KCsm #TSCsm #UroOnc
⏰ Only a few days until the post-#ASCO2021 #skincancer roundtable discussion! Join James Larkin, Rodabe Amaria, @AnaArance1, and @PAscierto as they cover the exciting developments in skin cancer! Don’t miss out and register now! #OncoAlert #VJSessions @ASCO @OncoAlert #SKCsm
VIDEO: RELATIVITY-047: relatlimab, an anti-LAG-3 antibody + nivolumab in first-line advanced melanoma w/ @evanlipson of @HopkinsMedicine 👨⚕️ Click here to watch 👉http://ow.ly/joce50FzGC2👈 @VJOncology @OncoAlert @ASCO #ASCO2021 #Melanoma #MELsm #SKCsm #Oncology #OncoAlert
Click below to see all the trial updates from ESMO WCGIC 2020!
Immunotherapy offers patients and physicians a wider plethora of options and is becoming increasingly prevalent in the GI cancer space.
Speaking to leading experts, we got the latest on this rapidly growing field.
By choosing to continue, you are confirming that you are a healthcare professional
Please enter your details if you would like to receive the latest oncology news and updates
Keep up to date with all the latest news with our monthly newsletter